Re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56

被引：0

作者：

Aldemir, Mustafa ^{[1
]}

Canda, Abdullah Erdem ^{[1
]}

Balbay, Mevlana Derya ^{[1
]}

机构：

[1] Ankara Ataturk Training & Res Hosp, TR-06800 Ankara, Turkey

来源：

EUROPEAN UROLOGY | 2010年 / 58卷 / 02期

关键词：

D O I：

10.1016/j.eururo.2010.05.032

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E23 / E23

页数：1

共 15 条

[1] Re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Lamm, Donald
Boehle, Andreas
Palou, Joan
Persad, Raj
Brausi, Maurizio
Colombel, Marc
Akaza, Hideyuki
Buckley, Roger
EUROPEAN UROLOGY, 2010, 57 (02) : E7 - E9
[2] Reply to Mustafa Aldemir and Abdullah Erdem Canda's Letter to the Editor re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Malmstrom, Per-Uno
Sylvester, Richard
EUROPEAN UROLOGY, 2010, 58 (02) : E24 - E25
[3] Reply to Donald Lamm, Andreas Bohle, Joan Palou, et al.'s Letter to the Editor re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Malmstrom, Per-Uno
Sylvester, Richard J.
EUROPEAN UROLOGY, 2010, 57 (02) : E10 - E11
[4] An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer
Malmstrom, Per-Uno
Sylvester, Richard J.
Crawford, David E.
Friedrich, Martin
Krege, Susanne
Rintala, Erkki
Solsona, Eduardo
Di Stasi, Savino M.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2009, 56 (02) : 247 - 256
[5] An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Gue'rin for Non-Muscle-Invasive Bladder Cancer
Ozer, Gokhan
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2009, 8 (02): : 61 - 66
[6] Rebuttal from Authors re: Richard J. Sylvester. Bacillus Calmette-Guerin versus Mitomycin C for the Treatment of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: The Debate Continues. Eur Urol 2009;56:266-8
Jarvinen, Riikka
Kaasinen, Eero
Sankila, Anna
Rintala, Erkki
EUROPEAN UROLOGY, 2009, 56 (02) : 268 - 269
[7] An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C Versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer - Long-Term Efficacy of Maintenance Bacillus Calmette-Guerin Versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent Tat1 Tumours Without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study With a 20-Year Follow-Up Editorial Comment
Montie, James E.
JOURNAL OF UROLOGY, 2010, 183 (06) : 2181 - 2183
[8] IMMUNOTHERAPY OR CHEMOTHERAPY AS LOCAL THERAPY OF URINARY BLADDER CANCER - WHICH IS THE MOST EFFECTIVE? REPORT ON A META-ANALYSIS OF THE LONG-TERM OUTCOME OF RANDOMIZED STUDIES COMPARING INTRAVESICAL MITOMYCIN C VERSUS BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE BLADDER CANCER
Malmstrom, P. U.
Sylvester, R.
Crawford, E. D.
Friedrich, M.
Krege, S.
Rintala, E.
Solsona, E.
Di Stasi, S. M.
Witjes, J. A.
EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 283 - 283
[9] Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Garg, Harshit
Nayak, Brusabhanu
Singh, Prabhjot
EUROPEAN UROLOGY, 2019, 75 (02) : E25 - E25
[10] Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Poletajew, Slawomir
Radziszewski, Piotr
Palou, Juan
EUROPEAN UROLOGY, 2017, 71 (01) : E29 - E30

← 1 2 →